beatandraise : SEC Filings Research with AI

beatandraise.com

2.2.0.25truefalse0502 - Disclosure - Acquisitions (Tables)truefalsefalse1falsefalsetruefalse{us-gaap_BusinessAcquisitionAxis} : Biovex Group Inc Member 1/1/2011 - 3/31/2011 Jan-01-2011_Mar-31-2011_Biovex_Group_Inc_Memberhttp://www.sec.gov/CIK0000318154duration2011-01-01T00:00:002011-03-31T00:00:00falsefalseBioVex Group Inc [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldiamgn_BiovexGroupIncMemberus-gaap_BusinessAcquisitionAxisexplicitMember2true0us-gaap_BusinessAcquisitionLineItemsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.falsefalseBusiness Acquisition [Line Items]3false0amgn_BusinessAcquisitionCostOfAcquiredEntityTextBlockamgnfalsenadurationAggregate acquisition date consideration to acquire an entity.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00  <div align="justify" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"> <div align="center"> <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">  <tr valign="bottom"> <td width="86%"> </td> <td width="5%"> </td> <td width="1%"> </td> <td width="8%"> </td> <td></td> </tr>   <tr valign="bottom" style="background: #cceeff"> <td> <div style="margin-left:15px; text-indent:-15px">Cash paid to former shareholders of BioVex </div></td> <td> </td> <td align="left">$</td> <td align="right">407</td> <td></td> </tr> <tr valign="bottom"> <td> <div style="margin-left:15px; text-indent:-15px">Fair value of contingent consideration obligations </div></td> <td> </td> <td> </td> <td align="right">190</td> <td></td> </tr> <tr style="font-size: 1px"> <td> <div style="margin-left:15px; text-indent:-15px">  </div></td> <td> </td> <td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td> <td></td> </tr> <tr valign="bottom" style="background: #cceeff"> <td> <div style="margin-left:30px; text-indent:-15px">Total consideration </div></td> <td> </td> <td align="left">$</td> <td align="right">597</td> <td></td> </tr> <tr style="font-size: 1px"> <td> <div style="margin-left:15px; text-indent:-15px">  </div></td> <td> </td> <td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td> <td></td> </tr>  </table> </div> </div> falsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringAggregate acquisition date consideration to acquire an entity.No authoritative reference available.falsefalseAggregate acquisition date consideration to acquire an entity4false0amgn_BusinessAcquisitionPurchasePriceAllocationTextBlockamgnfalsenadurationAllocation of the consideration to the acquisition date fair values of assets acquired and liabilities assumed.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00  <div align="justify" style="font-size: 10pt; font-family: 'Times New Roman',Times,serif"> <div align="center"> <table style="font-size: 10pt; text-align: left" cellspacing="0" border="0" cellpadding="0" width="100%">  <tr valign="bottom"> <td width="86%"> </td> <td width="5%"> </td> <td width="1%"> </td> <td width="8%"> </td> <td></td> </tr>   <tr valign="bottom" style="background: #cceeff"> <td> <div style="margin-left:15px; text-indent:-15px">Intangible assets — IPR&D </div></td> <td> </td> <td align="left">$</td> <td align="right">675</td> <td></td> </tr> <tr valign="bottom"> <td> <div style="margin-left:15px; text-indent:-15px">Goodwill </div></td> <td> </td> <td> </td> <td align="right">170</td> <td></td> </tr> <tr valign="bottom" style="background: #cceeff"> <td> <div style="margin-left:15px; text-indent:-15px">Deferred tax liabilities </div></td> <td> </td> <td nowrap="nowrap" align="left"> </td> <td align="right">(246</td> <td nowrap="nowrap">)</td> </tr> <tr valign="bottom"> <td> <div style="margin-left:15px; text-indent:-15px">Other assets and liabilities acquired, net </div></td> <td> </td> <td nowrap="nowrap" align="left"> </td> <td align="right">(2</td> <td nowrap="nowrap">)</td> </tr> <tr style="font-size: 1px"> <td> <div style="margin-left:15px; text-indent:-15px">  </div></td> <td> </td> <td nowrap="nowrap" colspan="2" align="right" style="border-top: 1px solid #000000"> </td> <td></td> </tr> <tr valign="bottom" style="background: #cceeff"> <td> <div style="margin-left:30px; text-indent:-15px">Total consideration </div></td> <td> </td> <td align="left">$</td> <td align="right">597</td> <td></td> </tr> <tr style="font-size: 1px"> <td> <div style="margin-left:15px; text-indent:-15px">  </div></td> <td> </td> <td nowrap="nowrap" colspan="2" align="right" style="border-top: 3px double #000000"> </td> <td></td> </tr>  </table> </div> </div> falsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringAllocation of the consideration to the acquisition date fair values of assets acquired and liabilities assumed.No authoritative reference available.falsefalseAllocation of the total consideration to the acquisition date fair values of assets acquired and liabilities assumed13Acquisitions (Tables) (BioVex Group Inc [Member])UnKnownUnKnownUnKnownUnKnownfalsetrue